{"id":"W4283644627","doi":"10.1016/s1470-2045(22)00160-7","title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","year":2022,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":448,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; McGill University Health Centre","funders":"National Institutes of Health; LEO Pharma; Servier; Astellas Pharma; Nippon Shinyaku; Société Académique de Genève; Incyte; International Society on Thrombosis and Haemostasis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Alnylam Pharmaceuticals; Daiichi-Sankyo; Teva Pharmaceutical Industries; Daiichi Sankyo Europe; Sanofi; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Celgene","keywords":"Medicine; Thrombosis; Rivaroxaban; Cancer; Venous thrombosis; Intensive care medicine; Apixaban; Internal medicine; Surgery; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001552709,0.0003344731,0.002762255,0.0001262945,0.0002063356,0.00001572032,0.0004134566,0.0001474075,0.0001291915],"category_scores_gemma":[0.0016327,0.0001489148,0.0001582782,0.0002490698,0.0002359705,0.00005336168,0.000264251,0.0004347507,0.000001038048],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001111436,"about_ca_system_score_gemma":0.001168934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007153135,"about_ca_topic_score_gemma":0.0004590164,"domain_scores_codex":[0.9973748,0.0004700166,0.0009322745,0.0004794545,0.0004232934,0.0003201974],"domain_scores_gemma":[0.9949443,0.002868222,0.001158625,0.0005294125,0.0004102595,0.00008921912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001447979,0.004810734,0.006755406,0.002231641,0.002525384,0.00001285758,0.0007411963,0.00003165969,5.264075e-9,0.0002386529,0.008397942,0.9728065],"study_design_scores_gemma":[0.007299964,0.01115499,0.01239212,0.0007119767,0.003259861,0.000006791078,0.0002189341,0.000007330214,2.036933e-8,0.00002088759,0.9647689,0.0001581639],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006744309,0.9660545,0.00004059151,0.01228703,0.001666297,0.01195238,0.0006089305,0.00003481328,0.0006111648],"genre_scores_gemma":[0.0003361271,0.9904625,0.0009398131,0.004412201,0.0006409721,0.002786648,0.0003223629,0.00005170817,0.00004764051],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9726484,"threshold_uncertainty_score":0.6072568,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2762548973384936,"score_gpt":0.5170136550109575,"score_spread":0.240758757672464,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}